A Bioequivalence Study of a New Paracetamol Oral Suspension 24mg/ml Compared to the Marketed Paracetamol Oral Suspension (Panadol Baby and Infant 24mg/ml) in Healthy Adult Subjects

NCT05022810 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: New Paracetamol Oral Suspension (24 mg/ml)
DRUG: Panadol B&I Oral Suspension (24 mg/ml paracetamol)

Sponsor

HALEON